Skip to content

CorMedix CRMD Deferred Tax Assets, Operating Loss Carryforwards, State and Local

Deferred Tax Assets, Operating Loss Carryforwards, State and Local at other companies

State Street logo
State StreetSTT
$21M+50.0%
Dime Community Bancshares
 logo
Dime Community Bancshares DCOM
$0
Opus Genetics logo
Opus GeneticsIRD
$0
Rockwell Automation logo
Rockwell AutomationROK
$62M-11.4%
Popular logo
PopularBPOP
$618.29M-6.6%
Dime Community Bancshares
 logo
Dime Community Bancshares DCOM
$0

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's deferred tax assets, operating loss carryforwards, state and local.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's deferred tax assets, operating loss carryforwards, state and local?
CorMedix (CRMD) reported deferred tax assets, operating loss carryforwards, state and local of $37.81M in Q4 2025.
How has CorMedix's deferred tax assets, operating loss carryforwards, state and local changed year-over-year?
CorMedix's deferred tax assets, operating loss carryforwards, state and local increased by 1240.8% year-over-year, from $2.82M to $37.81M.
What is the long-term trend for CorMedix's deferred tax assets, operating loss carryforwards, state and local?
Over 5 years (2020 to 2025), CorMedix's deferred tax assets, operating loss carryforwards, state and local has grown at a 66.5% compound annual growth rate (CAGR), from $2.96M to $37.81M.